Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Subscribe To Our Newsletter & Stay Updated
